CoChat

Modeling Oculopharyngeal Muscular Dystrophy in Myotube Cultures Reveals Reduced Accumulation of Soluble Mutant PABPN1 Protein

Raz, Vered, Routledge, Samantha, Venema, Andrea, Buijze, Hellen, van der Wal, Erik, Anvar, SeyedYahya, Straasheijm, Kirsten R., Klooster, Rinse, Antoniou, Michael, van der Maarel, Silvère M. · 2011 · The American Journal of Pathology
Cited by 42

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajpath.2011.06.044

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 53

  1. Cummings, 2000, Fourteen and counting: unraveling trinucleotide repeat diseases, Hum Mol Genet, 9, 909, 10.1093/hmg/9.6.909 · DOI · Paper page
  2. Albrecht, 2005, The other trinucleotide repeat: polyalanine expansion disorders, Curr Opin Genet Dev, 15, 285, 10.1016/j.gde.2005.04.003 · DOI · Paper page
  3. Brown, 2004, Alanine tracts: the expanding story of human illness and trinucleotide repeats, Trends Genet, 20, 51, 10.1016/j.tig.2003.11.002 · DOI · Paper page
  4. Ross, 2004, Protein aggregation and neurodegenerative disease, Nat Med, 10, S10, 10.1038/nm1066 · DOI · Paper page
  5. Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
  6. Wahle, 1991, A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation, Cell, 66, 759, 10.1016/0092-8674(91)90119-J · DOI · Paper page
  7. Wahle, 1995, 3′-end cleavage and polyadenylation of mRNA precursors, Biochim Biophys Acta, 1261, 183, 10.1016/0167-4781(94)00248-2 · DOI
  8. Bouchard, 1997, Recent studies on oculopharyngeal muscular dystrophy in Quebec, Neuromuscul Disord, 7, S22, 10.1016/S0960-8966(97)00077-1 · doi:10.1016/s0960-8966(97)00077-1
  9. Taylor, 1915, Progressive vagus-glossopharyngeal paralysis with ptosis: contribution the group of family diseases, J Nerv Ment Dis, 42, 129, 10.1097/00005053-191503000-00001 · doi:10.1097/00005053-191503000-00001
  10. Calado, 2000, Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA, Hum Mol Genet, 9, 2321, 10.1093/oxfordjournals.hmg.a018924 · DOI · Paper page
  11. Tome, 1980, Nuclear inclusions in oculopharyngeal dystrophy, Acta Neuropathol, 49, 85, 10.1007/BF00692226 · DOI
  12. Tome, 1997, Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy, Neuromuscul Disord, 7, S63, 10.1016/S0960-8966(97)00085-0 · DOI
  13. Berciano, 2004, Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus, Hum Mol Genet, 13, 829, 10.1093/hmg/ddh101 · DOI
  14. Villagra, 2008, Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions, Mol Cell Neurosci, 37, 622, 10.1016/j.mcn.2007.12.012 · DOI
  15. Klein, 2008, PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression, Exp Cell Res, 314, 1652, 10.1016/j.yexcr.2008.02.005 · doi:10.1016/j.yexcr.2008.02.005
  16. Tavanez, 2005, In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1, RNA, 11, 752, 10.1261/rna.7217105 · DOI
  17. Chartier, 2006, A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1, EMBO J, 25, 2253, 10.1038/sj.emboj.7601117 · DOI · Paper page
  18. Brais, 2009, Oculopharyngeal muscular dystrophy: a polyalanine myopathy, Curr Neurol Neurosci Rep, 9, 76, 10.1007/s11910-009-0012-y · DOI
  19. Catoire, 2008, Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1, Hum Mol Genet, 17, 2108, 10.1093/hmg/ddn109 · DOI · Paper page
  20. Davies, 2005, Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice, Nat Med, 11, 672, 10.1038/nm1242 · DOI · Paper page
  21. Chartier, 2009, Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo, Hum Mol Genet, 18, 1849, 10.1093/hmg/ddp101 · DOI
  22. Trollet, 2010, Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Hum Mol Genet, 19, 2191, 10.1093/hmg/ddq098 · DOI
  23. Blumen, 1999, Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease, Ann Neurol, 46, 115, 10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.0.CO;2-O · doi:10.1002/1531-8249(199907)46:1<115::aid-ana17>3.0.co;2-o
  24. Hino, 2004, Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy, Hum Mol Genet, 13, 181, 10.1093/hmg/ddh017 · DOI
  25. Apponi, 2010, Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis, Hum Mol Genet, 19, 1058, 10.1093/hmg/ddp569 · DOI · Paper page
  26. Kim, 2001, The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression, Hum Mol Genet, 10, 1129, 10.1093/hmg/10.11.1129 · DOI
  27. Wang, 2006, Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis, Biochem Biophys Res Commun, 340, 815, 10.1016/j.bbrc.2005.12.078 · doi:10.1016/j.bbrc.2005.12.078
  28. Anvar, 2011, Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients, Skelet Muscle, 1, 15, 10.1186/2044-5040-1-15 · DOI
  29. Needham, 1995, Further development of the locus control region/murine erythroleukemia expression system: high level expression and characterization of recombinant human calcitonin receptor, Protein Expr Purif, 6, 124, 10.1006/prep.1995.1015 · doi:10.1006/prep.1995.1015
  30. Tam, 2006, The human desmin locus: gene organization and LCR-mediated transcriptional control, Genomics, 87, 733, 10.1016/j.ygeno.2006.01.009 · DOI
  31. Chubet, 1996, Vectors for expression and secretion of FLAG epitope-tagged proteins in mammalian cells, Biotechniques, 20, 136, 10.2144/96201pf01 · DOI
  32. Morgan, 1994, Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines, Dev Biol, 162, 486, 10.1006/dbio.1994.1103 · DOI · Paper page
  33. Carmeli, 2002, The biochemistry of aging muscle, Exp Gerontol, 37, 477, 10.1016/S0531-5565(01)00220-0 · DOI · Paper page
  34. Goeman, 2004, A global test for groups of genes: testing association with a clinical outcome, Bioinformatics, 20, 93, 10.1093/bioinformatics/btg382 · DOI · Paper page
  35. Raz, 2006, Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells, J Cell Sci, 119, 4247, 10.1242/jcs.03180 · DOI
  36. Verheesen, 2006, Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody, Hum Mol Genet, 15, 105, 10.1093/hmg/ddi432 · DOI
  37. Abu-Baker, 2003, Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy, Hum Mol Genet, 12, 2609, 10.1093/hmg/ddg293 · DOI
  38. Bao, 2004, Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy, J Med Genet, 41, 47, 10.1136/jmg.2003.014548 · DOI
  39. Corbeil-Girard, 2005, PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions, Neurobiol Dis, 18, 551, 10.1016/j.nbd.2004.10.019 · DOI
  40. Klein, 2008, PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression, Exp Cell Res, 314, 1652, 10.1016/j.yexcr.2008.02.005 · doi:10.1016/j.yexcr.2008.02.005
  41. Messaed, 2007, Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy, Neurobiol Dis, 26, 546, 10.1016/j.nbd.2007.02.004 · DOI
  42. Antoniou, 1998, Efficient 3′-end formation of human beta-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reaction, Nucleic Acids Res, 26, 721, 10.1093/nar/26.3.721 · DOI · Paper page
  43. Collis, 1990, Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression, EMBO J, 9, 233, 10.1002/j.1460-2075.1990.tb08100.x · DOI · Paper page
  44. Custodio, 1999, Inefficient processing impairs release of RNA from the site of transcription, EMBO J, 18, 2855, 10.1093/emboj/18.10.2855 · DOI · Paper page
  45. Millevoi, 2002, A novel function for the U2AF 65 splicing factor in promoting pre-mRNA 3′-end processing, EMBO Rep, 3, 869, 10.1093/embo-reports/kvf173 · DOI
  46. Davies, 2008, Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation, Hum Mol Genet, 17, 1097, 10.1093/hmg/ddm382 · DOI
  47. Fan, 2001, Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death, Hum Mol Genet, 10, 2341, 10.1093/hmg/10.21.2341 · DOI
  48. Hjerpe, 2009, Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities, EMBO Rep, 10, 1250, 10.1038/embor.2009.192 · DOI · Paper page
  49. Lemay, 2010, Crossing the borders: poly(A)-binding proteins working on both sides of the fence, RNA Biol, 7, 291, 10.4161/rna.7.3.11649 · DOI
  50. Kuhn, 2004, Structure and function of poly(A) binding proteins, Biochim Biophys Acta, 1678, 67, 10.1016/j.bbaexp.2004.03.008 · DOI · Paper page
  51. Kühn, 2009, Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor, J Biol Chem, 284, 22803, 10.1074/jbc.M109.018226 · DOI · Paper page
  52. Junghans, 2009, Dystrophia myotonia: why focus on foci?, Eur J Hum Genet, 17, 543, 10.1038/ejhg.2008.227 · DOI
  53. de Mezer, 2011, Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference, Nucleic Acids Res, 39, 3852, 10.1093/nar/gkq1323 · DOI · Paper page

Metadata

Authors
Raz, V., Routledge, S., Venema, A., Buijze, H., van der Wal, E., Anvar, S., Straasheijm, K. R., Klooster, R., Antoniou, M., & van der Maarel, S. M.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2011-10
Volume
179
Issue
4
Pages
1988-2000
ISSN
0002-9440
Cited by
42
References
2
Language
en
Licence
Funders
  • Muscular Dystrophy Association (68015)
  • European Commission (POLYALA LSHM-CT-2005-018675, TRI-EX QLG2-CT-2001-01673)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.